Alpine Bank Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Sell
1,156
-95
-8% -$32.5K 0.05% 128
2026
Q1
$440K Buy
1,251
+355
+40% +$127K 0.06% 115
2025
Q4
$293K Sell
896
-45
-5% -$14.3K 0.04% 128
2025
Q3
$266K Buy
941
+8
+0.9% +$2.32K 0.04% 135
2025
Q2
$261K Sell
933
-100
-10% -$28.3K 0.04% 127
2025
Q1
$322K Buy
+1,033
New +$305K 0.05% 112
2024
Q3
$359K Buy
+1,115
New +$365K 0.06% 114

Other funds holding AMGN

Alpine Bank Wealth Management's AMGN Position: Q2 2026 in Review

Alpine Bank Wealth Management reduced its Amgen (AMGN) stake by 7.6% in Q2 2026, selling an estimated $32.5K and leaving 1,156 shares worth $419K. The position accounts for 0.05% of the portfolio, ranked #128.

Alpine Bank Wealth Management first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $440K in Q1 2026. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Alpine Bank Wealth Management held 1,156 shares of Amgen worth $419K as of Q2 2026.
  • Alpine Bank Wealth Management sold 95 Amgen shares in Q2 2026, an estimated $32.5K.
  • Amgen made up 0.05% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #128 holding.
  • Alpine Bank Wealth Management first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • Alpine Bank Wealth Management's Amgen position peaked at $440K in Q1 2026.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.